AnaptysBio
ANAB
ANAB
136 hedge funds and large institutions have $601M invested in AnaptysBio in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 45 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
+4
Holders Change %
+3.03%
% of All Funds
2.41%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
23
Increased
36
Reduced
45
Closed
19
Calls
$4.6M
Puts
$1.67M
Net Calls
+$2.94M
Net Calls Change
+$4.19M
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$25.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$16.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.16M |
| 4 |
GA
Greenspring Associates
Owings Mills,
Maryland
|
+$3.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.36M |
Top Sellers
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$30.5M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$18.1M |
| 3 |
SC
Sessa Capital
New York
|
-$7.76M |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$5.63M |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
-$4.88M |